MANNATECH INC Deferred Tax Liabilities, Gross
MANNATECH INC (MTEX) had Deferred Tax Liabilities, Gross of $11.13 million as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-04-15
- 2025-12-31: Deferred Tax Liabilities, Gross $11.13M.
- 2024-12-31: Deferred Tax Liabilities, Gross $1.38M.
- 2023-12-31: Deferred Tax Liabilities, Gross $1.79M.
- 2022-12-31: Deferred Tax Liabilities, Gross $1.24M.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2025-12-31 | $11.13M 10-K · filed 2026-04-15 |
| 2024-12-31 | $1.38M 10-K · filed 2026-04-15 |
| 2023-12-31 | $1.79M 10-K · filed 2025-03-26 |
| 2022-12-31 | $1.24M 10-K · filed 2024-03-28 |
| 2021-12-31 | $1.65M 10-K · filed 2023-03-17 |
| 2020-12-31 | $1.94M 10-K · filed 2022-03-15 |
| 2019-12-31 | $2.50M 10-K · filed 2021-03-19 |
| 2018-12-31 | $1.11M 10-K · filed 2020-03-26 |
| 2017-12-31 | $1.43M 10-K · filed 2019-03-11 |
| 2017-09-30 | $31.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $30.00K 10-Q · filed 2017-08-08 |
| 2016-12-31 | $1.50M 10-K · filed 2018-03-26 |
| 2015-12-31 | $1.52M 10-K · filed 2017-03-14 |
| 2014-12-31 | $1.23M 10-K · filed 2016-03-15 |
| 2013-12-31 | $2.53M 10-K · filed 2015-03-10 |
| 2012-12-31 | $2.39M 10-K · filed 2014-03-18 |
| 2011-12-31 | $2.77M 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |